ARCHIVES

Study Finds High-Risk Women Reluctant To Take Tamoxifen

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

February 15, 2013

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

Clinical Research: Cooperative Groups Form Coalition to Advance Trials

November 14, 1997

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987